M&A TRANSACTION · 2024
Vantive Kidney Care (Baxter) acquired by Carlyle
$3.80B· Medical Devices
Acquirer
Carlyle
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$4513.0M
EBITDA
-
Deal Value
$3.80B
What's your medical devices worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $3.80B acquisition of Vantive Kidney Care (Baxter) by Carlyle sits in the medical devices sub-vertical. Run a valuation for your own medical devices business via our Medical Devices valuation hub. Carlyle is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the Vantive Kidney Care (Baxter) acquisition.
More on medical devices valuations
- Value a medical devices· run the calculator
- Medical Devices median multiples· real-deal benchmarks
- Who buys medical devices businesses?· active buyers
- Who acquired Owen Mumford Holdings?· buyer profile
- How to value a medical devices· long-form guide